DAX+0,69 % EUR/USD-0,12 % Gold+0,04 % Öl (Brent)-1,26 %

Teleflex Announces 100,000 Patients Treated for Enlarged Prostate with UroLift System

Nachrichtenquelle: Business Wire (engl.)
20.02.2019, 23:00  |  303   |   |   

Teleflex Incorporated (NYSE:TFX) today announced that 100,000 patients have been treated globally with its minimally invasive UroLift System, a safe and effective treatment for men with Benign Prostatic Hyperplasia (BPH) that provides rapid symptom relief and improved quality of life while preserving sexual function.*1,2

BPH, also known as enlarged prostate, is a common condition marked by bothersome urinary symptoms that can cause loss of productivity, depression, interrupted sleep, and decreased quality of life.3 BPH affects over 40 million men in the United States alone.4 If left untreated, the condition can worsen over time and cause permanent bladder damage.5

“We are extremely proud to see the vast number of patients that have benefited from this minimally invasive technology, and we look forward to helping even more men achieve the same rapid, durable relief from BPH symptoms,” said Dave Amerson, president of the Teleflex Interventional Urology Business Unit. “Reaching this milestone is a significant achievement for not only the entire Interventional Urology team, but also for the physicians who are committed to using the UroLift System to provide exemplary care so that their patients can experience relief from the burdensome symptoms of BPH.”

“The vast majority of patients with BPH are under the impression that medication or invasive surgery are the only available options to treat their symptoms; however, more and more physicians are recommending the UroLift System treatment to their patients because it doesn’t carry the long-term side effects of other BPH treatments,” said Peter Walter**, M.D., F.A.C.S., of Western New York Urology Associates in Jamestown, NY. “After treating men using the UroLift System and observing the positive outcomes in their symptom relief and overall quality of life, I chose the UroLift System as my own treatment for my BPH symptoms.”

“The UroLift System has become an accepted standard of care treatment for men with enlarged prostate and the Prostatic Urethral Lift (PUL) is now recommended by the American Urologic Association BPH Treatment Guidelines,” said Steven Gange**, M.D., F.A.C.S., Summit Urology Group, Salt Lake City, Utah. “The symptoms associated with enlarged prostate can be extremely disruptive and burdensome, affecting the daily life of men with this condition. Fortunately, the UroLift System treatment allows men in diverse patient populations to experience significant improvements in BPH symptoms while preserving their sexual function*1,2, without requiring major surgery or the use of ongoing BPH medication. The ultimate result is these patients return to a better quality of life.”

Seite 1 von 2
Wertpapier
Teleflex
Mehr zum Thema
EuroIntervention


0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel